Screener
DexCom DXCM Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from DexCom’s reported figures.
Based on trailing twelve months.
The source filing: DexCom’s 8-K, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 4:03 PM EDT
- Accession
- 0001093557-26-000142
FAQ
- What is DexCom's return on equity?
- DexCom (DXCM) reported return on equity of 38.5% in Q2 2026.
- How has DexCom's return on equity changed year-over-year?
- DexCom's return on equity increased by 68.6% year-over-year, from 22.8% to 38.5%.
- What is the long-term trend for DexCom's return on equity?
- Over 5 years (2020 to 2025), DexCom's return on equity has grown at a -5.2% compound annual growth rate (CAGR), from 45.2% to 34.5%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about DexCom's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude